Waldmeier, Peter: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Modulation of dopaminergic transmission by alpha-noradrenergic agonists and antagonists: Evidence for antidopaminergic properties of some alpha antagonists

Peter C. Waldmeier, Rainer Ortmann, Serge Bischoff

Journal:

Cellular and Molecular Life Sciences

Year:

1982

Language:

english

File:

PDF, 982 KB

english, 1982

2

Discrimination of neuroleptics by means of their interaction with amfonelic acid: An attempt to characterize the test

Peter C. Waldmeier, Hans Huber, Micheline Heinrich, Kurt Stoecklin

Journal:

Biochemical Pharmacology

Year:

1985

Language:

english

File:

PDF, 721 KB

english, 1985

3

Blood-brain barrier penetration of 3-aminopropyl-n-butylphosphinic acid (CGP 36742) in rat brain by microdialysis/mass spectrometry

Andrén, Per E., Emmett, Mark R., DaGue, Beverly B., Steulet, Anne-Françoise, Waldmeier, Peter, Caprioli, Richard M.

Journal:

Journal of Mass Spectrometry

Year:

1998

Language:

english

File:

PDF, 340 KB

english, 1998

4

Antagonism of baclofen's effects on rat striatal 5-HT metabolism: A model for 5-HT agonistic properties?

Dr. Peter C. Waldmeier, Bruno Fehr

Journal:

Drug Development Research

Year:

1982

Language:

english

File:

PDF, 693 KB

english, 1982

5

Nucleoside und Nucleotide. Teil 14. Synthese des Octanucleosidheptaphosphats d(G-A-T-T-T-T-G-A)

Peter Bühlmayer, Georg Graf, Felix Waldmeier, Christoph Tamm

Journal:

Helvetica Chimica Acta

Year:

1980

File:

PDF, 1.04 MB

1980

6

Nucleosides and Nucleotides. Part 21. Synthesis of a Tridecanucleoside Dodecaphosphate Incorporating the Unnatural Base 2 (1 H)-Pyridone

Silvio De Bernardini, Georg Graf, Colin A. Leach, Peter Bühlmayer, Felix Waldmeier, Christoph Tamm

Journal:

Helvetica Chimica Acta

Year:

1983

Language:

english

File:

PDF, 650 KB

english, 1983

7

An automated fluorometric method for the estimation of dopamine in brain tissue extracts

Peter Waldmeier, Laurent Maître

Journal:

Analytical Biochemistry

Year:

1973

Language:

english

File:

PDF, 401 KB

english, 1973

8

The dimerization, polymerization, and hydrolysis of FeIII-4,4′,4″,4″′-tetrasulfophthalocyanine

Helmut Sigel, Peter Waldmeier, Bernhard Prijs

Journal:

Inorganic and Nuclear Chemistry Letters

Year:

1971

Language:

english

File:

PDF, 339 KB

english, 1971

9

Pharmacokinetics of valsartan in patients with liver disease

Brookman, Laurence J., Rolan, Paul E., Benjamin, Irving S., Palmer, Kelvin R., Wyld, Peter J., Lloyd, Peter, Flesch, Gérard, Waldmeier, Felix, Sioufi, Antoine, Mullins, Frank

Journal:

Clinical Pharmacology & Therapeutics

Year:

1997

Language:

english

File:

PDF, 646 KB

english, 1997

10

Synthesis of tools for target identification of the anti-apoptotic compound CGP 3466; Part I

Kaspar Zimmermann, Silvio Roggo, Eddy Kragten, Peter Fürst, Peter Waldmeier

Journal:

Bioorganic & Medicinal Chemistry Letters

Year:

1998

Language:

english

File:

PDF, 389 KB

english, 1998

11

Effects of the putative P-type calcium channel blocker, R,R-(−)-daurisoline on neurotransmitter release

Peter C. Waldmeier, Peter Wicki, Wolfgang Fröstl, Helmut Bittiger, Jean-Jacques Feldtrauer

Journal:

Naunyn-Schmiedeberg's Archives of Pharmacology

Year:

1995

Language:

english

File:

PDF, 973 KB

english, 1995

12

Phenylethylamine and phenylacetic acid in CSF of schizophrenics and healthy controls

Helmut Beckmann, Gavin P. Reynolds, Merton Sandler, Peter Waldmeier, Joachim Lauber, Peter Riederer, Wagner F. Gattaz

Journal:

European Archives of Psychiatry and Clinical Neuroscience

Year:

1982

Language:

english

File:

PDF, 509 KB

english, 1982

13

Clinical pharmacology of the new COMT inhibitor CGP 28 014

Peter R. Bieck, Karl-Heinz Antonin, Gisbert Farger, Erik B. Nilsson, Eckhart K. Schmidt, Philippe Dostert, Margherita Strolin Benedetti, Peter C. Waldmeier

Journal:

Neurochemical Research

Year:

1993

Language:

english

File:

PDF, 403 KB

english, 1993

14

Effects of CGP 28014 on the in vivo release and metabolism of dopamine in the rat striatum assessed by brain microdialysis

Anne-Françoise Steulet, Kurt Stöcklin, Peter Wicki, Peter Waldmeier

Journal:

Neurochemical Research

Year:

1993

Language:

english

File:

PDF, 577 KB

english, 1993

15

Roles of GABABreceptor subtypes in presynaptic auto- and heteroreceptor function regulating GABA and glutamate release

Peter C. Waldmeier, Klemens Kaupmann, Stephan Urwyler

Journal:

Journal of Neural Transmission

Year:

2008

Language:

english

File:

PDF, 430 KB

english, 2008

16

Roles of GABABreceptor subtypes in presynaptic auto- and heteroreceptor function regulating GABA and glutamate release

Peter C. Waldmeier, Klemens Kaupmann, Stephan Urwyler

Journal:

Journal of Neural Transmission

Year:

2009

Language:

english

File:

PDF, 128 KB

english, 2009

17

Hyperdopaminergia and altered locomotor activity in GABAB1-deficient mice

Claire-Marie Vacher, Martin Gassmann, Sandrine Desrayaud, Etienne Challet, Amyaouch Bradaia, Daniel Hoyer, Peter Waldmeier, Klemens Kaupmann, Paul Pévet, Bernhard Bettler

Journal:

Journal of Neurochemistry

Year:

2006

Language:

english

File:

PDF, 718 KB

english, 2006

18

p28, A Novel ERGIC/cis Golgi Protein, Required for Golgi Ribbon Formation

Eva Koegler, Carine Bonnon, Lorenz Waldmeier, Sandra Mitrovic, Regula Halbeisen, Hans-Peter Hauri

Journal:

Year:

2010

Language:

english

File:

PDF, 2.19 MB

english, 2010

19

The Nonimmunosuppressive Cyclosporin Analogs NIM811 and UNIL025 Display Nanomolar Potencies on Permeability Transition in Brain-Derived Mitochondria

Magnus J. Hansson, Gustav Mattiasson, Roland Månsson, Jenny Karlsson, Marcus F. Keep, Peter Waldmeier, Urs T. Ruegg, Jean-Maurice Dumont, Kamel Besseghir, Eskil Elmér

Journal:

Journal of Bioenergetics and Biomembranes

Year:

2004

Language:

english

File:

PDF, 396 KB

english, 2004

20

The GABABantagonist, CGP 35348, antagonizes the effects of baclofen, γ-butyrolactone and HA 966 on rat striatal dopamine synthesis

Peter C. Waldmeier

Journal:

Naunyn-Schmiedeberg's Archives of Pharmacology

Year:

1991

Language:

english

File:

PDF, 678 KB

english, 1991

21

Release of endogenous glutamate from rat cortical slices in presence of the glutamate uptake inhibitor L-trans-pyrrolidine-2,4-dicarboxylic acid

Peter C. Waldmeier, Peter Wicki, Jean-Jacques Feldtrauer

Journal:

Naunyn-Schmiedeberg's Archives of Pharmacology

Year:

1993

Language:

english

File:

PDF, 863 KB

english, 1993

22

Interactions of isamoltane (CGP 361A), an anxiolytic phenoxypropanolamine derivative, with 5-HT1, receptor subtypes in the rat brain

Peter C. Waldmeier, Michael Williams, Peter A. Baumann, Serge Bischoff, Matthew A. Sills, Robert F. Neale

Journal:

Naunyn-Schmiedeberg's Archives of Pharmacology

Year:

1988

Language:

english

File:

PDF, 1.31 MB

english, 1988

23

On the role of α-methyldopamine in the antihypertensive effect of α-methyldopa

Peter Waldmeier, Phyllis R. Hedwall, Laurent Maître

Journal:

Naunyn-Schmiedeberg's Archives of Pharmacology

Year:

1975

Language:

english

File:

PDF, 662 KB

english, 1975

24

Stimulation of central serotonin turnover byβ-adrenoceptor agonists

Peter C. Waldmeier

Journal:

Naunyn-Schmiedeberg's Archives of Pharmacology

Year:

1981

Language:

english

File:

PDF, 520 KB

english, 1981

25

On the reversibility of reversible MAO inhibitors

Peter C. Waldmeier

Journal:

Naunyn-Schmiedeberg's Archives of Pharmacology

Year:

1985

Language:

english

File:

PDF, 683 KB

english, 1985

26

Effects of CGP 11305 A, a new reversible and selective inhibitor of MAO A, on biogenic amine levels and metabolism in the rat brain

Peter C. Waldmeier, Peter A. Baumann

Journal:

Naunyn-Schmiedeberg's Archives of Pharmacology

Year:

1983

Language:

english

File:

PDF, 669 KB

english, 1983

27

Recent clinical failures in Parkinson's disease with apoptosis inhibitors underline the need for a paradigm shift in drug discovery for neurodegenerative diseases

Peter Waldmeier, Donna Bozyczko-Coyne, Michael Williams, Jeffry L. Vaught

Journal:

Biochemical Pharmacology

Year:

2006

Language:

english

File:

PDF, 324 KB

english, 2006

28

Pimecrolimus: Skin disposition after topical administration in minipigs in vivo and in human skin in vitro

Hans-Peter Gschwind, Felix Waldmeier, Markus Zollinger, Alain Schweitzer, Maximilian Grassberger

Journal:

European Journal of Pharmaceutical Sciences

Year:

2008

Language:

english

File:

PDF, 633 KB

english, 2008

29

Metabolism and disposition of the oral absorption enhancer 14C-radiolabeled 8-(N-2-hydroxy-5-chlorobenzoyl)-amino-caprylic acid (5-CNAC) in healthy postmenopausal women and supplementary investigations in vitro

Hans-Peter Gschwind, Ulrike Glaenzel, Felix Waldmeier, Bernard Wirz, Helene D. Sabia, Franck Picard, H. Markus Weiss, Leslie Choi, Pieter Jacob Swart, Ajithkumar Vasudevan, Moïse Azria

Journal:

European Journal of Pharmaceutical Sciences

Year:

2012

Language:

english

File:

PDF, 908 KB

english, 2012

30

Differences in pre- and post-synaptic sensitivity to apomorphine between saline and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57BL/6 mice as reflected in climbing activity

Will P.J.M Spooren, Annick Vassout, Peter Waldmeier, Conrad Gentsch

Journal:

European Journal of Pharmacology

Year:

1998

Language:

english

File:

PDF, 102 KB

english, 1998

31

Morpholin-2-yl-phosphinic acids are potent GABAB receptor antagonists in rat brain

Jennifer Ong, David I.B. Kerr, Helmut Bittiger, Peter C. Waldmeier, Peter A. Baumann, Nigel G. Cooke, Stuart J. Mickel, Wolfgang Froestl

Journal:

European Journal of Pharmacology

Year:

1998

Language:

english

File:

PDF, 321 KB

english, 1998

32

Interrupting apoptosis in neurodegenerative disease: potential for effective therapy?

Peter C Waldmeier, William G Tatton

Journal:

Drug Discovery Today

Year:

2004

Language:

english

File:

PDF, 71 KB

english, 2004

33

MECHANISMS OF ACTION OF LITHIUM IN AFFECTIVE DISORDERS: A STATUS REPORT

Peter. C. Waldmeier

Journal:

Basic & Clinical Pharmacology & Toxicology

Year:

1990

Language:

english

File:

PDF, 1.81 MB

english, 1990

34

Simultaneous measurement of Ca2+ transients and of membrane depolarizations in synaptosomes

Martin Ochsner, Thomas Fleck, Peter Waldmeier

Journal:

Biochemical and Biophysical Research Communications

Year:

1991

Language:

english

File:

PDF, 430 KB

english, 1991

35

Deprenil: loss of selectivity for inhibition of B-type MAO after repeated treatment

Peter C. Waldmeier, Aina E. Felner

Journal:

Biochemical Pharmacology

Year:

1978

Language:

english

File:

PDF, 191 KB

english, 1978

36

Cumulative effects of irreversible MAO inhibitors in vivo

Aina E. Felner, Peter C. Waldmeier

Journal:

Biochemical Pharmacology

Year:

1979

Language:

english

File:

PDF, 843 KB

english, 1979

37

The inhibition of monoamine oxidase by brofaromine

Mary C. Anderson, Peter C. Waldmeier, Keith F. Tipton

Journal:

Biochemical Pharmacology

Year:

1991

Language:

english

File:

PDF, 816 KB

english, 1991

38

Inhibition of catechol-O-methyltransferase (COMT) as well as tyrosine and tryptophan hydroxylase by the orally active iron chelator, 1,2-dimethyl-3-hydroxypyridin-4-one (L1, CP20), in rat brain in vivo

Peter C. Waldmeier, Anne-Marthe Buchle, Anne-Françoise Steulet

Journal:

Biochemical Pharmacology

Year:

1993

Language:

english

File:

PDF, 1.02 MB

english, 1993

39

Serotonin-dopamine interactions in the nigrostriatal system

Peter C. Waldmeier, Alexandra A. Delini-Stula

Journal:

European Journal of Pharmacology

Year:

1979

Language:

english

File:

PDF, 822 KB

english, 1979

40

Analysis of the activation of dopamine metabolism by a serotonin uptake inhibitor

Peter C. Waldmeier

Journal:

European Journal of Pharmacology

Year:

1979

Language:

english

File:

PDF, 650 KB

english, 1979

41

Biphasic effects of some dopamine agonists on striatal acetylcholine concentrations

Peter C. Waldmeier

Journal:

European Journal of Pharmacology

Year:

1983

Language:

english

File:

PDF, 462 KB

english, 1983

42

Reversibility of the interaction of CGP 11305 A with MAO A in vivo

Peter C. Waldmeier, Jean-Jacques Feldtrauer, Kurt Stoecklin, Eva Paul

Journal:

European Journal of Pharmacology

Year:

1983

Language:

english

File:

PDF, 524 KB

english, 1983

43

The monoamine oxidase inhibiting properties of CGP 11305 A

Peter C. Waldmeier, Aina E. Felner, Keith F. Tipton

Journal:

European Journal of Pharmacology

Year:

1983

Language:

english

File:

PDF, 697 KB

english, 1983

44

CGP 4718 A, a new potential antidepressant with a dual mode of action

Peter C. Waldmeier, Keith F. Tipton, Raymond Bernasconi, Aina E. Felner, Peter A. Baumann, Laurent Maitre

Journal:

European Journal of Pharmacology

Year:

1984

Language:

english

File:

PDF, 724 KB

english, 1984

45

Affinity changes of rat striatal dopamine receptors in vivo after acute bupropion treatment

Serge Bischoff, Helmut Bittiger, Jutta Krauss, Annick Vassout, Peter Waldmeier

Journal:

European Journal of Pharmacology

Year:

1984

Language:

english

File:

PDF, 252 KB

english, 1984

46

Ifoxetine, a compound with atypical effects on serotonin uptake

Peter C. Waldmeier, Laurent Maître, Peter A. Baumann, Kathleen Hauser, Serge Bischoff, Helmut Bittiger, Romeo Paioni

Journal:

European Journal of Pharmacology

Year:

1986

Language:

english

File:

PDF, 742 KB

english, 1986

47

Comparison of [18F]FDOPA, [18F]FMT and [18F]FECNT for imaging dopaminergic neurotransmission in mice

Michael Honer, Bastian Hengerer, Milen Blagoev, Samuel Hintermann, Peter Waldmeier, Pius A. Schubiger, Simon M. Ametamey

Journal:

Nuclear Medicine and Biology

Year:

2006

Language:

english

File:

PDF, 275 KB

english, 2006

48

Determination of rat brain and plasma levels of the orally active GABAB antagonist 3-amino-propyl-n-butyl-phosphinic acid (CGP 36742) by a new GC/MS method

Anne-Françoise Steulet, Hans-Jörg Möbius, Stuart J. Mickel, Kurt Stöcklin, Peter C. Waldmeier

Journal:

Biochemical Pharmacology

Year:

1996

Language:

english

File:

PDF, 699 KB

english, 1996

49

Prospects for antiapoptotic drug therapy of neurodegenerative diseases

Peter C. Waldmeier

Journal:

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Year:

2003

Language:

english

File:

PDF, 394 KB

english, 2003

50

Pharmacokinetics and metabolism of formestane in breast cancer patients

Per Eystein Lønning, Jürgen Geisler, Dag Clement Johannessen, Hans-Peter Gschwind, Felix Waldmeier, Werner Schneider, Bruno Galli, Tammo Winkler, Wolfgang Blum, Hans-Peter Kriemler, William Russell Mi

Journal:

The Journal of Steroid Biochemistry and Molecular Biology

Year:

2001

Language:

english

File:

PDF, 192 KB

english, 2001